Articles at Genital-Herpes-Facts
|
Genital Herpes Article
Herpes Treatment - Treat Herpes
from:What is genital herpes? About Herpes Treatment: Genital herpes
is an infection caused by the herpes simplex virus or HSV. There
are two types of HSV, and both can cause genital herpes. HSV
type 1 most commonly infects the lips, causing sores known as
fever blisters or cold sores, but it also can infect the genital
area and produce sores. HSV type 2 is the usual cause of genital
herpes, but it also can infect the mouth. A person who has
genital herpes infection can easily pass or transmit the virus
to an uninfected person during sex. Herpes infections most
commonly occur in the mouth, but can also occur in the genital
areas and in the around the eyes. Some common symptoms are
swelling, redness, clusters of blisters, fever, headache,
fatigue, pain, and blurred vision. These symptoms are often the
worst during the first infection.
Herdox is a natural Herpes Treatment supplement that is designed
to be helpful for reducing the severity and occurrences of
Herpes outbreaks while also shortening healing time. One study
on the ingredients in Herdox suggested the following:
May reduce the number of herpes outbreaks
May reduce the severity of herpes outbreaks
May reduce healing time By providing your body with the proper
nutrients, it can naturally fight back against the herpes virus
and help you take control of your life. Click here to read more
about the ingredients in Herdox.
Both HSV 1 and 2 can produce sores (also called lesions) in and
around the vaginal area, on the penis, around the anal opening,
and on the buttocks or thighs. Occasionally, sores also appear
on other parts of the body where the virus has entered through
broken skin.
HSV remains in certain nerve cells of the body for life, and can
produce symptoms off and on in some infected people.
According to the U.S. Centers for Disease Control and
Prevention, 45 million people in the United States ages 12 and
older, or 1 out of 5 of the total adolescent and adult
population, are infected with HSV-2.
Nationwide, since the late 1970s, the number of people with
genital herpes infection has increased 30 percent. The largest
increase is occurring in young teens. HSV-2 infection is more
common in three of the youngest age groups which include people
aged 12 to 39 years.
Learn more about
Herpes Treatment at http://www.herpes-treatment.us.
About the author:
J. Ratliff is an article writer for http://www.askwellness.com
Other Genital Herpes related Articles
My First Year With Herpes Or How I Was Re Born A Modern Day Leper
The Incredible Mystical Formidable Herpes Virus
Geital Herpes
How To Deal With Herpes Rejection
Be Herpes Free
Do you want to contribute to our site : submit your articles HERE
Genital Herpes News
Antigenics Presents Positive, Top Line Data From Phase I Herpes Clinical Trial
Antigenics (NASDAQ: AGEN) announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2 (HSV-2), the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells. "I believe these data represent the first finding of their ...
Read more...Antigenics announces positive result for AG-707 to treat genital herpes
Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.
Read more...Antigenics posts positive herpes drug study data
Antigenics reported positive data Tuesday from an early stage clinical therapy trial to treat herpes simplex virus-2, the virus that causes genital herpes.
Read more...Antigenics shares up on progress with herpes drug
NEW YORK (MarketWatch) - Antigenics Inc. shares leaped 20% in Tuesday trading. The Salt Lake City biotechnology company, which is focused on treatments for cancer and infectious diseases, reported progress in a Phase I trial of AG-707, a drug under development to treat herpes simplex virus-2, the virus that causes genital herpes. "Being able to impact and possibly decrease the spread of genital ...
Read more...Collaboration Solves Structure Of Herpes Virus Protein, Provides New Drug Directions
The mechanism by which a herpes virus invades cells has remained a mystery to scientists, but now research from Tufts University and the University of Pennsylvania reveals the unusual structure of a key member of the protein complex that allows a herpes virus to invade cells.The new map details an essential piece of the herpes virus cell-entry machinery, providing scientists with a new target ...
Read more...